五鼎生物技術股份有限公司
五鼎生物技術股份有限公司（Apex Biotechnology Corp.）研發、製造與銷售血糖、尿酸、血紅素等監測系統，以及農藥殘留檢測系統。提供照護管理與遠距醫療服務。公司成立於 1997 年，總部位於台灣新竹。
該股 RSI(6) 為 31.6，處於中性區間，短線無明顯超買超賣訊號。股價站上60日、120日均線，跌破5日、20日均線。KD 指標中性（K=42.4）；MACD 柱狀體為負值，空方動能持續。 （自動產生 · 非投資建議）
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 08-11 | -8 | 0 | -26 | -34 |
| 08-10 | -157 | 0 | 0 | -157 |
| 08-07 | +31 | 0 | +1 | +32 |
| 08-06 | -45 | 0 | -3 | -48 |
| 08-05 | -40 | 0 | -7 | -47 |
| 08-04 | -32 | 0 | -11 | -43 |
| 08-03 | +213 | 0 | -1 | +212 |
| 07-31 | -96 | 0 | +1 | -95 |
| 07-30 | -25 | 0 | +3 | -22 |
| 07-29 | +99 | 0 | +7 | +106 |
| 07-28 | +19 | 0 | +7 | +26 |
| 07-27 | +3 | 0 | 0 | +3 |
| 07-24 | +177 | 0 | 0 | +177 |
| 07-23 | -41 | 0 | 0 | -41 |
| 07-22 | -32 | 0 | +1 | -31 |
| 07-21 | +30 | 0 | 0 | +30 |
| 07-20 | +47 | 0 | +10 | +57 |
| 07-17 | -20 | 0 | +4 | -16 |
| 07-16 | +188 | 0 | 0 | +188 |
| 07-15 | +179 | 0 | 0 | +179 |
| 07-14 | +63 | 0 | +1 | +64 |
| 07-13 | +50 | 0 | -1 | +49 |
| 07-09 | +137 | 0 | +1 | +138 |
| 07-08 | -91 | 0 | 0 | -91 |
| 07-07 | -1 | 0 | 0 | -1 |
| 07-06 | +77 | 0 | 0 | +77 |
| 07-03 | +49 | 0 | 0 | +49 |
| 07-02 | +65 | 0 | 0 | +65 |
| 07-01 | +13 | 0 | 0 | +13 |
| 06-30 | -32 | 0 | 0 | -32 |
| 06-29 | +65 | 0 | 0 | +65 |
| 06-26 | -57 | 0 | -1 | -58 |
| 06-25 | -7 | 0 | 0 | -7 |
| 06-24 | +44 | 0 | 0 | +44 |
| 06-22 | +29 | 0 | +1 | +30 |
| 06-18 | -15 | 0 | +1 | -14 |
| 06-17 | +1 | 0 | 0 | +1 |
| 06-16 | -65 | 0 | -2 | -67 |
| 06-15 | +2 | 0 | +7 | +9 |
| 06-12 | -10 | 0 | +9 | -1 |
| 06-10 | -2 | 0 | -1 | -3 |
| 06-09 | -157 | 0 | -27 | -184 |
| 06-08 | -94 | 0 | 0 | -94 |
| 06-04 | +82 | 0 | 0 | +82 |
| 06-03 | +68 | 0 | 0 | +68 |
| 06-02 | +93 | 0 | -2 | +91 |
| 06-01 | +94 | 0 | +9 | +103 |
| 05-29 | +159 | 0 | -2 | +157 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/06 | 1.74 億 | +19.4% | +20.1% |
| 2026/05 | 1.46 億 | -3.6% | -18.1% |
| 2026/04 | 1.51 億 | +6.8% | -19.3% |
| 2026/03 | 1.41 億 | -20.7% | -24.1% |
| 2026/02 | 1.78 億 | -10.9% | -12.0% |
| 2026/01 | 2.00 億 | +39.9% | +17.9% |
| 2025/12 | 1.43 億 | +1.8% | -16.1% |
| 2025/11 | 1.40 億 | -9.7% | +10.9% |
| 2025/10 | 1.56 億 | -14.1% | -0.8% |
| 2025/09 | 1.81 億 | +23.3% | -2.9% |
| 2025/08 | 1.47 億 | +34.5% | -19.9% |
| 2025/07 | 1.09 億 | - | -21.9% |